NCT07475364

Brief Summary

The goal of this clinical trial is to compare the efficacy of lesion sterilization and tissue repair (LSTR) antibiotic paste versus zinc oxide eugenol (ZOE) pulpectomy for the treatment of primary molars with pulp necrosis in pediatric patients. The main questions it aims to answer are:

  • Is LSTR antibiotic paste (CTZ paste) effective in treating primary molars with pulp necrosis?
  • Is ZOE pulpectomy effective in treating primary molars with pulp necrosis, and how does its efficacy compare with LSTR therapy? Researchers will compare LSTR therapy (Group A) with ZOE pulpectomy (Group B) to determine which treatment provides better clinical and radiographic outcomes after six months. Participants will:
  • Be randomly assigned to one of the two treatment groups after diagnosis of pulp necrosis in primary molars.
  • Receive treatment under standard behavior management techniques with local anesthesia following topical application of 2% lignocaine gel and rubber dam isolation.
  • Undergo either Lesion Sterilization and Tissue Repair (LSTR) therapy with CTZ paste or zinc oxide eugenol (ZOE) pulpectomy according to group allocation.
  • Return for a clinical and radiographic follow-up evaluation after six months to assess treatment outcomes.
  • Allow researchers to record their clinical findings and radiographic results to evaluate the efficacy of both treatment methods.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for phase_1

Timeline
9mo left

Started May 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress26%
May 2026May 2027

First Submitted

Initial submission to the registry

March 11, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 16, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Last Updated

March 19, 2026

Status Verified

March 1, 2026

Enrollment Period

7 months

First QC Date

March 11, 2026

Last Update Submit

March 16, 2026

Conditions

Keywords

LSTR therapyprimary molarspulp therapy

Outcome Measures

Primary Outcomes (2)

  • Number of Participants with Clinical Success

    Clinical success will be assessed based on the absence of sinus tract, soft tissue swelling, or edema associated with the treated primary molar during follow-up clinical examination.

    6 months

  • Number of Participants with Radiographic Success

    Radiographic success will be assessed by reduction or complete disappearance of the initial periapical radiolucency and absence of any newly developed radiolucency on follow-up periapical radiographs of the treated tooth.

    6 months after treatment

Secondary Outcomes (1)

  • Reduction in Periapical Radiolucency

    baseline and 6 months

Study Arms (2)

LSTR therapy

EXPERIMENTAL

Participants in this group receive CTZ antibiotic paste placed in the pulp chamber after irrigation.

Drug: Group A - LSTR Therapy (CTZ Paste)

Zinc Oxide Eugenol (ZOE) Pulpectomy

ACTIVE COMPARATOR

Participants in this group receive conventional pulpectomy with ZOE paste placed in the root canals.

Procedure: Group B - ZOE Pulpectomy

Interventions

Placement of CTZ antibiotic paste (chloramphenicol, tetracycline, zinc oxide mixed with eugenol) in the pulp chamber after irrigation with 3% sodium hypochlorite, followed by restoration with resin-modified glass ionomer cement.

LSTR therapy

Intervention: Conventional pulpectomy including working length determination, canal debridement with K-files and 3% sodium hypochlorite irrigation, followed by obturation with zinc oxide eugenol paste and final restoration with resin-modified glass ionomer cement.

Zinc Oxide Eugenol (ZOE) Pulpectomy

Eligibility Criteria

Age4 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children of both genders
  • years and 10 years
  • Pulp necrosis in mandibular primary molars with minimum of 2/3 of the roots
  • Consent from Parents/Guardian of children.
  • Sufficient crown structure for restoration

You may not qualify if:

  • Children who have a physical or mental change.
  • Involving systemic illnesses.
  • History of allergy to drugs being utilized
  • Antibiotics use within three months
  • Teeth with aberrant root resorption or pulp canal obliteration on periapical radiography

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Dental Pulp Necrosis

Condition Hierarchy (Ancestors)

Dental Pulp DiseasesTooth DiseasesStomatognathic DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 11, 2026

First Posted

March 16, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

May 1, 2027

Last Updated

March 19, 2026

Record last verified: 2026-03